Contamination of the active substance Ranitidine with N-nitrosodimethylamine (NDMA) was detected, constituting a quality defect and a potential risk to patients’ health. Potential effects: possible toxic and carcinogenic effects during long-term use.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from the listed batches; check the batch number on the packaging and, if you have it, return the medicine to a pharmacy or consult a doctor or pharmacist.
The Chief Pharmaceutical Inspector withdrew the specified batches of the medicinal product Riflux from the market throughout the country and granted the decision immediate enforceability, obliging the...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related